PolyNovo (ASX:PNV) has announced that Bruce Rathie has retired as a non-executive director.
Mr Rathie has been a director of the company since 2010. The company said Mr Rathie has supported its development from initial research and development to product commercialisation, public listing, and subsequent global expansion.
PolyNovo is focused on products that simplify the management of acute complex wounds. Its NovoSorb BTM is a dermal scaffold that regenerates the dermis when lost through extensive surgery, trauma, or burns.
PolyNovo chairman David Williams said, “Bruce has been the one constant on the PolyNovo Board. He has been there from the start and the rest of us are standing on his shoulders. After 14 years Bruce has selflessly decided to stand aside to make way for new blood and concentrate on his other Board roles. He will be missed but I am confident he will still be available for his sage advice.”
